Skip to main content
Fig. 1 | Stem Cell Research & Therapy

Fig. 1

From: Allogeneic transplantation of programmable cells of monocytic origin (PCMO) improves angiogenesis and tissue recovery in critical limb ischemia (CLI): a translational approach

Fig. 1

Experimental protocol includes (a) cell culture experiments of PCMO evaluating the potential pro-angiogenic effect in vitro, (b) animal studies examining the potential effect of treatment with PCMO in contrast to application of native monocytes/placebo group and (c) a series of individual healing attemps in patients with peripheral arterial disease (Rutherford, stage 5 and 6) without further curative treatment options. HUVEC human umbilical vein endothelial cells, PCMO programmable cells of monocytic origin

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512